Isolates of Pseudomonas aeruginosa (167) were obtained from 528 samples of canine otitis externa,
The most common pathogens in the etiology of otitis include members of the Staphylococcus genus (8, 9) and Gramnegative rods. Despite Gram-negative microorganisms are not routinely cultured from the normal ear canal, Proteus mirabilis, Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa have been described and cannot be neglected as agents of canine otitis externa (5) .
Pseudomonas aeruginosa is a Gram-negative rod which is nonspore forming and aerobe. In dogs, P. aeruginosa have already been reported on otitis media/external infections (4, 6) .
The bacterium can be resistant to all classes of antimicrobial agents making it especially difficult to successfully treat patients with compromised immune defenses (8) Hundred and sixty-seven out of the 528 studied samples yielded Pseudomonas aeruginosa in pure culture, representing 31.6% of the total isolates. These isolates were all resistant to multiple antimicrobial classes, including intrinsic as well as acquired resistance to newer synthetic antimicrobial agents that are commonly used in canine practice.
Highly variable susceptibility profiles were observed among these isolates, what has been extensively discussed (11, 12) . For example, some isolates were resistant to the aminoglycosides (amikacin, gentamicin, and tobramycin) while susceptible to the fluoroquinolones and vice versa.
With regards to cephalosporins, significant rates of resistance were presented, with 60.8% resistant isolates to ceftriaxone and 52.8% to ceftazidime. These results agrees Penna, B. et al. Antimicrobial resistance of P. aeruginosa with other studies which also observed high rates of resistance to cephaloporins ranging from 97% to 100% (11).
Resistance to aminoglycosides was frequently observed; neomycin and gentamicin were the less effective drugs of this class, with 94.7% and 71.4% of the isolates being resistant, respectively. Additionally, tobramycin did not present good efficiency rates, since 65.4% of the isolates were resistant to this drug. These findings clearly contrast with findings of a recent study conducted in Canada (11) that reported P.
aeruginosa isolates coming from canine otitis externa to be highly susceptible to those drugs (11) .
In relation to the class of the fluoroquinolones, ciprofloxacin and norfloxacin demonstrated very similar rates of resistance, with 13.8% and 18.4% of resistant strains, respectively, while ciprofloxacin was the most effective drug of this study. The high susceptibility to the fluoroquinolones was expected, since other studies also highlight the efficiency of drugs from this class in the treatment of P. aeruginosa canine infections (13) . Ciprofloxacin have been reported (11) to be the best drug among the fluoroquinolones, with only 16% of isolates presenting resistance to this drug.
What was unexpected was the high rate of resistance to enrofloxacin, since 63.6% of the isolates recovered in this study were resistant to this drug, what contrasts to other reports (11) of only 31% of resistant isolates to enrofloxacin. This phenomenon of a high resistance to enrofloxacin not being accompanied by other fluoroquinolones has already been reported in studies regarding canine hosts (13).
In conclusion, the antimicrobial resistance of P.
aeruginosa isolates taken from cases of canine otitis externa demonstrates an alarming scenario in Rio de Janeiro, Brazil.
Those data would also argue for the early consideration of culture and sensitivity testing in the management of cases of otitis externa that are not responding to empiric therapy.
